Onsdag 28 Oktober | 20:04:23 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

Respiratorius Q2 2023 - A waiting game ahead

2023-08-09 08:20:00

Redeye provides its outlook on Respiratorius following its Q2 2023 report. The company focuses on the partnering process, which is material for the investment case. However, apart from that, the remaining part of 2023 is expected to be uneventful.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/